December 6, 2022

Coronavirus Omicron variant India live updates: Weekly average toll dips for 3rd day in row – The Times of India

Officials at trial sites set to test Bharat Biotech’s intranasal vaccine against Covid-19, ‘BBV154’, told TOI on Tuesday that with the fastspreading Omicron in circulation, it would be a challenge to find volunteers who haven’t been infected yet. Dr Aniket Joshi, principal investigator for the trial at Oyster & Pearl Hospitals, Pune, said participants at the trial have to fulfil two key criteria — they should have no medical history of Covid, and must be unvaccinated.

Leave a Reply

Your email address will not be published. Required fields are marked *